<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Business Leaders ME | Qatar &amp; Middle East Business News Magazine</title>
	<atom:link href="https://businessleadersme.com/tag/qatar-foundation/feed/" rel="self" type="application/rss+xml" />
	<link>https://businessleadersme.com/tag/qatar-foundation/</link>
	<description>Turning Milestones into Headlines</description>
	<lastBuildDate>Mon, 23 Feb 2026 08:39:33 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://businessleadersme.com/wp-content/uploads/2026/02/bl-favicon-150x150.png</url>
	<title>Business Leaders ME | Qatar &amp; Middle East Business News Magazine</title>
	<link>https://businessleadersme.com/tag/qatar-foundation/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>HH Sheikha Moza bint Nasser Attends Opening of Precision Medicine and the Future of Genomics Summit 2025</title>
		<link>https://businessleadersme.com/hh-sheikha-moza-bint-nasser-attends-opening-of-precision-medicine-and-the-future-of-genomics-summit-2025/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Tue, 02 Dec 2025 18:12:21 +0000</pubDate>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Sub News]]></category>
		<category><![CDATA[Top News]]></category>
		<category><![CDATA[AI in genomics]]></category>
		<category><![CDATA[clinical trials Qatar]]></category>
		<category><![CDATA[genomic research Qatar]]></category>
		<category><![CDATA[Genomics Summit Qatar]]></category>
		<category><![CDATA[HH Sheikha Moza bint Nasser]]></category>
		<category><![CDATA[PMFG 2025]]></category>
		<category><![CDATA[population genomics Qatar]]></category>
		<category><![CDATA[precision medicine Qatar]]></category>
		<category><![CDATA[Qatar Foundation]]></category>
		<category><![CDATA[Qatar healthcare innovation]]></category>
		<category><![CDATA[Qatar National Convention Centre]]></category>
		<category><![CDATA[Qatar Precision Health Institute]]></category>
		<category><![CDATA[Sidra Medicine]]></category>
		<guid isPermaLink="false">https://businessleadersme.com/?p=3211</guid>

					<description><![CDATA[<p>Qatar Foundation and Sidra Medicine highlight 11 years of groundbreaking progress in Precision Health and Genomics. Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), attended the opening of the Precision Medicine and the Future of Genomics (PMFG) Summit 2025, held at the Qatar National Convention Centre (QNCC). The prestigious event marks more than a decade of Qatar’s leadership and investment in precision medicine, genomics, and health innovation. The ceremony was also attended by HE Mansoor bin Ebrahim bin Saad Al Mahmoud, Minister of Public Health, alongside senior government officials, diplomats, and global healthcare and academic leaders — underscoring Qatar’s commitment to advancing the future of healthcare. A Decade of Milestones in Precision Medicine The PMFG Summit 2025 opened with keynote addresses from Julia Vitarello, Founder &#38; CEO of Mila’s Miracle Foundation, and Prof. Ed Liu from The Jackson Laboratory. The ceremony concluded with the flagship panel discussion:“From Personalised to Population-Scale: Building a Thriving Precision Medicine Sector in Qatar.” In his remarks, Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine, stated: “As we celebrate 11 years of PMFG, we reaffirm our commitment to advancing genomic science, translational research, and precision health implementation. We extend our appreciation to all speakers, partners, sponsors, and the growing scientific community in Qatar who make this summit truly exceptional.” Driving the Future of Genomics and Healthcare Innovation Co-organised by Sidra Medicine and the Qatar Precision Health Institute, and held under the patronage of Qatar Foundation, the PMFG Summit focuses on three major transformative pillars shaping the next era of global healthcare: The summit brings together global experts to explore how genomics, technology, and clinical strategy can be integrated into population-wide healthcare transformation — positioning Qatar as a frontrunner in precision medicine. What’s Ahead on Day 2 – December 3 The second day of PMFG 2025 will feature: As Qatar continues shaping a world-class ecosystem for precision health, the PMFG Summit stands as a cornerstone of its national vision to lead scientific discovery, improve patient outcomes, and build a sustainable healthcare future.</p>
<p>The post <a href="https://businessleadersme.com/hh-sheikha-moza-bint-nasser-attends-opening-of-precision-medicine-and-the-future-of-genomics-summit-2025/">HH Sheikha Moza bint Nasser Attends Opening of Precision Medicine and the Future of Genomics Summit 2025</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="3211" class="elementor elementor-3211" data-elementor-post-type="post">
				<div class="elementor-element elementor-element-7821e32b e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent" data-id="7821e32b" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-3b4ee895 elementor-widget elementor-widget-text-editor" data-id="3b4ee895" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
									
<p class="wp-block-paragraph"><strong>Qatar Foundation and Sidra Medicine highlight 11 years of groundbreaking progress in Precision Health and Genomics.</strong></p>

<p class="wp-block-paragraph">Her Highness <strong>Sheikha Moza bint Nasser</strong>, Chairperson of <strong>Qatar Foundation (QF)</strong>, attended the opening of the <strong>Precision Medicine and the Future of Genomics (PMFG) Summit 2025</strong>, held at the <strong>Qatar National Convention Centre (QNCC)</strong>. The prestigious event marks more than a decade of Qatar’s leadership and investment in <strong>precision medicine, genomics, and health innovation</strong>.</p>
<p><img decoding="async" src="https://businessleadersme.com/wp-content/uploads/2025/12/2-1024x839.jpg" /></p>

<p class="wp-block-paragraph">The ceremony was also attended by <strong>HE Mansoor bin Ebrahim bin Saad Al Mahmoud</strong>, Minister of Public Health, alongside senior government officials, diplomats, and global healthcare and academic leaders — underscoring Qatar’s commitment to advancing the future of healthcare.</p>

<p class="wp-block-paragraph"><strong>A Decade of Milestones in Precision Medicine</strong></p>

<p class="wp-block-paragraph">The PMFG Summit 2025 opened with keynote addresses from <strong>Julia Vitarello</strong>, Founder &amp; CEO of <em>Mila’s Miracle Foundation</em>, and <strong>Prof. Ed Liu</strong> from <em>The Jackson Laboratory</em>. The ceremony concluded with the flagship panel discussion:<br /><strong>“From Personalised to Population-Scale: Building a Thriving Precision Medicine Sector in Qatar.”</strong></p>

<p class="wp-block-paragraph">In his remarks, <strong>Prof. Khalid Fakhro</strong>, Chief Research Officer at <strong>Sidra Medicine</strong>, stated:</p>

<p class="wp-block-paragraph">“As we celebrate 11 years of PMFG, we reaffirm our commitment to advancing genomic science, translational research, and precision health implementation. We extend our appreciation to all speakers, partners, sponsors, and the growing scientific community in Qatar who make this summit truly exceptional.”</p>
<p><img decoding="async" src="https://businessleadersme.com/wp-content/uploads/2025/12/3-1024x683.jpg" /></p>

<p class="wp-block-paragraph"><strong>Driving the Future of Genomics and Healthcare Innovation</strong></p>

<p class="wp-block-paragraph">Co-organised by <strong>Sidra Medicine</strong> and the <strong>Qatar Precision Health Institute</strong>, and held under the patronage of <strong>Qatar Foundation</strong>, the PMFG Summit focuses on three major transformative pillars shaping the next era of global healthcare:</p>

<ul class="wp-block-list">
<li><strong>AI in Genomics, Clinical Trials, and Real-World Implementation</strong></li>

<li><strong>Precision Medicine &amp; Population Genomics</strong></li>

<li><strong>Future Frontiers in Genomic Research and Innovation</strong></li>
</ul>

<p class="wp-block-paragraph">The summit brings together global experts to explore how genomics, technology, and clinical strategy can be integrated into <strong>population-wide healthcare transformation</strong> — positioning Qatar as a frontrunner in precision medicine.</p>
<p><img decoding="async" src="https://businessleadersme.com/wp-content/uploads/2025/12/6-1024x683.jpg" /></p>

<p class="wp-block-paragraph"><strong>What’s Ahead on Day 2 – December 3</strong></p>

<p class="wp-block-paragraph">The second day of PMFG 2025 will feature:</p>

<ul class="wp-block-list">
<li><strong>Opening Plenary Lecture</strong> by <strong>Dr Stephen Kingsmore</strong> on rapid genome sequencing in clinical care</li>

<li>A <strong>high-level panel</strong> with leaders from the biotechnology, investment, and innovation sectors</li>

<li>Sessions on <strong>clinical trials, rare disease therapeutics, and translational medicine</strong></li>

<li>Strategic discussions on <strong>AI-driven healthcare</strong>, genomic data systems, and future innovation pathways</li>
</ul>

<p class="wp-block-paragraph">As Qatar continues shaping a world-class ecosystem for <strong>precision health</strong>, the PMFG Summit stands as a cornerstone of its national vision to lead scientific discovery, improve patient outcomes, and build a sustainable healthcare future.</p>
								</div>
					</div>
				</div>
				</div>
		<p>The post <a href="https://businessleadersme.com/hh-sheikha-moza-bint-nasser-attends-opening-of-precision-medicine-and-the-future-of-genomics-summit-2025/">HH Sheikha Moza bint Nasser Attends Opening of Precision Medicine and the Future of Genomics Summit 2025</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>A National Milestone in Pediatric Care</title>
		<link>https://businessleadersme.com/a-national-milestone-in-pediatric-care/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Tue, 03 Jun 2025 13:42:59 +0000</pubDate>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Top News]]></category>
		<category><![CDATA[bone marrow transplant in Qatar]]></category>
		<category><![CDATA[CAR-T in Qatar]]></category>
		<category><![CDATA[GMP cell therapy]]></category>
		<category><![CDATA[Her Highness Sheikha Moza bint Nasser]]></category>
		<category><![CDATA[HSCT ward Qatar]]></category>
		<category><![CDATA[pediatric stem cell transplant]]></category>
		<category><![CDATA[Qatar Foundation]]></category>
		<category><![CDATA[Qatar National Vision 2030]]></category>
		<category><![CDATA[regenerative medicine GCC]]></category>
		<category><![CDATA[sickle cell care]]></category>
		<category><![CDATA[Sidra Medicine]]></category>
		<category><![CDATA[thalassemia gene therapy]]></category>
		<guid isPermaLink="false">https://businessleadersme.com/?p=2791</guid>

					<description><![CDATA[<p>Her Highness Sheikha Moza bint Nasser Inaugurates Pediatric Stem Cell Transplant Ward at Sidra Medicine Sidra Medicine, a member of Qatar Foundation, proudly announces the official inauguration of its state-of-the-art Pediatric Hematopoietic Stem Cell Transplant (HSCT) Ward, launched under the patronage of Her Highness Sheikha Moza bint Nasser. This marks a groundbreaking advancement in Qatar’s pediatric healthcare landscape — the country’s first dedicated ward offering bone marrow transplant services to children with complex blood disorders, genetic diseases, and immune system conditions. The new HSCT Ward is designed exclusively for patients under 18 years of age, delivering highly specialised care for conditions such as: Treatments include autologous (self-donated) and allogeneic (donor-based) hematopoietic stem cell transplants, also known as bone marrow transplants. Precision Medicine Meets Global Standards Sidra Medicine’s HSCT program is a cornerstone of its precision medicine strategy. The new ward features: This launch supports Qatar’s healthcare goals under Qatar National Vision 2030, including: As of mid-2025, the HSCT ward will begin autologous transplants, with preparations underway for allogeneic procedures. Future phases will include CAR-T cell therapies and Casgevy gene therapy for thalassemia and sickle cell disease. Dr. Iyabo Tinubu-Karch, CEO of Sidra Medicine: “The HSCT program strengthens our commitment to providing world-class, family-centered care—right here in Qatar.” Prof. Ibrahim Janahi, Chief Medical Officer: “This initiative is a major step toward building a knowledge-based, innovation-driven health system in line with Qatar’s national goals.” The HSCT Program at Sidra Medicine is open to both Qatari and international patients. More than 50 children are currently awaiting transplantation, and new patient referrals are now being accepted. To learn more about our Pediatric Hematology, Oncology, and HSCT services, or to refer a patient, please visit:🔗 www.sidra.org  </p>
<p>The post <a href="https://businessleadersme.com/a-national-milestone-in-pediatric-care/">A National Milestone in Pediatric Care</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="2791" class="elementor elementor-2791" data-elementor-post-type="post">
				<div class="elementor-element elementor-element-27e17f40 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent" data-id="27e17f40" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-5943f1da elementor-widget elementor-widget-text-editor" data-id="5943f1da" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
									
<h3 class="wp-block-heading">Her Highness Sheikha Moza bint Nasser Inaugurates Pediatric Stem Cell Transplant Ward at Sidra Medicine</h3>

<p class="wp-block-paragraph"><strong>Sidra Medicine</strong>, a member of <strong>Qatar Foundation</strong>, proudly announces the official inauguration of its state-of-the-art <strong>Pediatric Hematopoietic Stem Cell Transplant (HSCT) Ward</strong>, launched under the patronage of <strong>Her Highness Sheikha Moza bint Nasser</strong>.</p>
<p><img decoding="async" src="https://businessleadersme.com/wp-content/uploads/2025/06/Her-Highness-Sheikha-Moza-bint-Nasser-at-Sidra-Medicine-1-1024x683.jpg" /></p>

<p class="wp-block-paragraph">This marks a groundbreaking advancement in Qatar’s pediatric healthcare landscape — the country’s first dedicated ward offering <strong>bone marrow transplant services</strong> to children with complex blood disorders, genetic diseases, and immune system conditions.</p>

<h2 class="wp-block-heading">Specialised Care for Our Youngest Patients</h2>

<p class="wp-block-paragraph">The new <strong>HSCT Ward</strong> is designed exclusively for patients under 18 years of age, delivering highly specialised care for conditions such as:</p>

<ul class="wp-block-list">
<li>Leukemia and lymphoma</li>

<li>Thalassemia and sickle cell disease</li>

<li>Immune deficiencies</li>

<li>Metabolic and rare genetic disorders</li>
</ul>

<p class="wp-block-paragraph">Treatments include autologous (self-donated) and allogeneic (donor-based) hematopoietic stem cell transplants, also known as <strong>bone marrow transplants</strong>.<img decoding="async" class="wp-image-2793" src="https://businessleadersme.com/wp-content/uploads/2025/06/Her-Highness-Sheikha-Moza-bint-Nasser-at-Sidra-Medicine-2-1024x683.jpg" alt="" /></p>

<h2 class="wp-block-heading"><img decoding="async" src="https://businessleadersme.com/wp-content/uploads/2025/06/Her-Highness-Sheikha-Moza-bint-Nasser-at-Sidra-Medicine-2-1024x683.jpg" /></h2>
<h2 class="wp-block-heading">Precision Medicine Meets Global Standards</h2>

<p class="wp-block-paragraph">Sidra Medicine’s HSCT program is a cornerstone of its precision medicine strategy. The new ward features:</p>

<ul class="wp-block-list">
<li><strong>20-bed capacity</strong> designed for HSCT and hematology-oncology inpatients</li>

<li><strong>High-level isolation facilities</strong> that meet global infection control standards</li>

<li>Access to <strong>Good Manufacturing Practice (GMP)</strong>-certified stem cell processing and cryopreservation</li>

<li>A <strong>multidisciplinary care team</strong> including hematologists, oncologists, immunologists, psychologists, pharmacists, nutritionists, and child life experts</li>
</ul>

<h2 class="wp-block-heading">Building Qatar’s Future in Regenerative Medicine</h2>

<p class="wp-block-paragraph">This launch supports Qatar’s healthcare goals under <strong>Qatar National Vision 2030</strong>, including:</p>

<ul class="wp-block-list">
<li>Reducing outbound patient referrals</li>

<li>Expanding regional access to advanced therapies</li>

<li>Developing national expertise in <strong>cell and gene therapies</strong></li>
</ul>

<p class="wp-block-paragraph">As of mid-2025, the HSCT ward will begin <strong>autologous transplants</strong>, with preparations underway for <strong>allogeneic procedures</strong>. Future phases will include <strong>CAR-T cell therapies</strong> and <strong>Casgevy</strong> gene therapy for thalassemia and sickle cell disease.</p>

<h2 class="wp-block-heading">Leadership Voices</h2>

<p class="wp-block-paragraph"><strong>Dr. Iyabo Tinubu-Karch</strong>, CEO of Sidra Medicine:</p>

<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">
<h4 style="text-align: center;"><span style="color: #ff0000;">“The HSCT program strengthens our commitment to providing world-class, family-centered care—right here in Qatar.”</span></h4>
</blockquote>

<p class="wp-block-paragraph"><strong>Prof. Ibrahim Janahi</strong>, Chief Medical Officer:</p>

<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">
<h4 style="text-align: center;"><span style="color: #ff0000;">“This initiative is a major step toward building a knowledge-based, innovation-driven health system in line with Qatar’s national goals.”</span></h4>
</blockquote>

<h2 class="wp-block-heading">Serving Local &amp; International Families</h2>

<p class="wp-block-paragraph">The <strong>HSCT Program at Sidra Medicine</strong> is open to both Qatari and international patients. More than <strong>50 children are currently awaiting transplantation</strong>, and new patient referrals are now being accepted.</p>

<p class="wp-block-paragraph">To learn more about our <strong>Pediatric Hematology, Oncology, and HSCT services</strong>, or to refer a patient, please visit:<br />🔗 <a class="" href="https://www.sidra.org">www.sidra.org</a></p>

<p class="wp-block-paragraph"> </p>
								</div>
					</div>
				</div>
				</div>
		<p>The post <a href="https://businessleadersme.com/a-national-milestone-in-pediatric-care/">A National Milestone in Pediatric Care</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Sidra Medicine and İzmir Biomedicine and Genome Center (IBG) Sign MoU to Advance Pediatric Biomedical Research</title>
		<link>https://businessleadersme.com/sidra-medicine-and-izmir-biomedicine-and-genome-center-ibg-sign-mou-to-advance-pediatric-biomedical-research/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Wed, 19 Mar 2025 07:21:54 +0000</pubDate>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[animal models]]></category>
		<category><![CDATA[biobanking]]></category>
		<category><![CDATA[bioinformatics]]></category>
		<category><![CDATA[genomics collaboration]]></category>
		<category><![CDATA[IBG]]></category>
		<category><![CDATA[İzmir Biomedicine and Genome Center]]></category>
		<category><![CDATA[knowledge exchange]]></category>
		<category><![CDATA[Memorandum of Understanding]]></category>
		<category><![CDATA[MoU]]></category>
		<category><![CDATA[multi-omics]]></category>
		<category><![CDATA[pediatric biomedical research]]></category>
		<category><![CDATA[Pediatric Healthcare]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[Qatar Foundation]]></category>
		<category><![CDATA[rare diseases]]></category>
		<category><![CDATA[research partnership]]></category>
		<category><![CDATA[scientific innovation]]></category>
		<category><![CDATA[Sidra Medicine]]></category>
		<category><![CDATA[stem cell research]]></category>
		<category><![CDATA[translational research]]></category>
		<category><![CDATA[Turkey biomedical research]]></category>
		<guid isPermaLink="false">https://businessleadersme.com/?p=2373</guid>

					<description><![CDATA[<p>Strengthening Collaboration in Genomics, Precision Medicine, and Translational Research 18 March 2025, Doha, Qatar &#8211; Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MoU) with the İzmir Biomedicine and Genome Center (IBG) to enhance collaboration in pediatric biomedical research. The agreement marks a significant milestone in fostering scientific research, innovation, and knowledge exchange between the two institutions. Dr. Iyabo Tinubu-Karch, Chief Executive Officer at Sidra Medicine, emphasized the significance of the partnership, stating: “The MoU with IBG is a major step in accelerating genomic discoveries for rare diseases. Our collaboration will focus on key areas including biobanking, genomics and multi-omics, bioinformatics, animal models of disease, and stem cell research. By working together, we aim to advance precision medicine and develop groundbreaking solutions for children with complex medical conditions.” Prof. Yılmaz, Director of IBG, said: “Partnering with Sidra Medicine, a globally recognized leader in pediatric healthcare and research, reinforces our commitment to advancing biomedical research. This collaboration will enable us to make meaningful strides in genomic and translational medicine, ultimately improving healthcare outcomes for children globally.” The partnership with IBG will also establish a framework for collaborative research projects, academic exchanges, and the sharing of expertise in key areas such as genomics, precision medicine, and translational research. By combining resources and knowledge, Sidra Medicine and IBG aim to address critical health challenges affecting children worldwide. Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine said: “Our agreement with IBG will also enable student exchanges and visiting scientist programs in both directions between Qatar and Turkey, as well as joint grant applications. Additionally, we will establish research cohorts with similar disorders across the MENAT region, helping us gain deeper insights into disease patterns and therapeutic interventions.” The agreement paves the way for future joint initiatives, including research collaborations, training programs, and knowledge-sharing efforts that will benefit both institutions and the broader scientific community.</p>
<p>The post <a href="https://businessleadersme.com/sidra-medicine-and-izmir-biomedicine-and-genome-center-ibg-sign-mou-to-advance-pediatric-biomedical-research/">Sidra Medicine and İzmir Biomedicine and Genome Center (IBG) Sign MoU to Advance Pediatric Biomedical Research</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="2373" class="elementor elementor-2373" data-elementor-post-type="post">
				<div class="elementor-element elementor-element-6561ad86 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent" data-id="6561ad86" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-768353e4 elementor-widget elementor-widget-text-editor" data-id="768353e4" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
									
<p class="wp-block-paragraph"><em>Strengthening Collaboration in Genomics, Precision Medicine, and Translational Research</em></p>

<p class="wp-block-paragraph"><strong>18</strong><strong> March 2025, Doha, Qatar &#8211; </strong><a href="https://www.sidra.org/">Sidra Medicine</a>, a member of Qatar Foundation, has signed a Memorandum of Understanding (MoU) with the <a href="https://www.ibg.edu.tr/">İzmir Biomedicine and Genome Center</a> (IBG) to enhance collaboration in pediatric biomedical research. The agreement marks a significant milestone in fostering scientific research, innovation, and knowledge exchange between the two institutions.</p>

<p class="wp-block-paragraph"><a href="https://www.sidra.org/peoples/dr-iyabo-tinubu-karch-3/">Dr. Iyabo Tinubu-Karch</a>, Chief Executive Officer at Sidra Medicine, emphasized the significance of the partnership, stating: “The MoU with IBG is a major step in accelerating genomic discoveries for rare diseases. Our collaboration will focus on key areas including biobanking, genomics and multi-omics, bioinformatics, animal models of disease, and stem cell research. By working together, we aim to advance precision medicine and develop groundbreaking solutions for children with complex medical conditions.”</p>

<p class="wp-block-paragraph"><a href="https://www.ibg.edu.tr/about/director">Prof. Yılmaz</a>, Director of IBG, said: “Partnering with Sidra Medicine, a globally recognized leader in pediatric healthcare and research, reinforces our commitment to advancing biomedical research. This collaboration will enable us to make meaningful strides in genomic and translational medicine, ultimately improving healthcare outcomes for children globally.”</p>

<p class="wp-block-paragraph">The partnership with IBG will also establish a framework for collaborative research projects, academic exchanges, and the sharing of expertise in key areas such as genomics, precision medicine, and translational research. By combining resources and knowledge, Sidra Medicine and IBG aim to address critical health challenges affecting children worldwide.</p>

<p class="wp-block-paragraph"><a href="https://www.sidra.org/about-us/governance-and-leadership/chief-executive-team/dr-khalid-fakhro">Prof. Khalid Fakhro</a>, Chief Research Officer at Sidra Medicine said: “Our agreement with IBG will also enable student exchanges and visiting scientist programs in both directions between Qatar and Turkey, as well as joint grant applications. Additionally, we will establish research cohorts with similar disorders across the MENAT region, helping us gain deeper insights into disease patterns and therapeutic interventions.” The agreement paves the way for future joint initiatives, including research collaborations, training programs, and knowledge-sharing efforts that will benefit both institutions and the broader scientific community.</p>
								</div>
					</div>
				</div>
				</div>
		<p>The post <a href="https://businessleadersme.com/sidra-medicine-and-izmir-biomedicine-and-genome-center-ibg-sign-mou-to-advance-pediatric-biomedical-research/">Sidra Medicine and İzmir Biomedicine and Genome Center (IBG) Sign MoU to Advance Pediatric Biomedical Research</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Sidra Medicine Study Identifies New Non-Invasive Method for Detecting Heart Disease Risk</title>
		<link>https://businessleadersme.com/sidra-medicine-study-identifies-new-non-invasive-method-for-detecting-heart-disease-risk/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Wed, 12 Mar 2025 05:52:49 +0000</pubDate>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Annalisa Terranegra]]></category>
		<category><![CDATA[blood test]]></category>
		<category><![CDATA[cardiovascular disease]]></category>
		<category><![CDATA[early diagnosis]]></category>
		<category><![CDATA[heart disease markers]]></category>
		<category><![CDATA[Jean Charles Grivel]]></category>
		<category><![CDATA[non-invasive diagnostics]]></category>
		<category><![CDATA[personalized healthcare]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[protein biomarkers]]></category>
		<category><![CDATA[Qatar Biobank]]></category>
		<category><![CDATA[Qatar Foundation]]></category>
		<category><![CDATA[Qatar National Research Fund]]></category>
		<category><![CDATA[saliva test]]></category>
		<category><![CDATA[Scientific Reports]]></category>
		<category><![CDATA[Sidra Medicine]]></category>
		<category><![CDATA[Souhaila Al Khodor]]></category>
		<guid isPermaLink="false">https://businessleadersme.com/?p=2281</guid>

					<description><![CDATA[<p>Breakthrough Study Identifies Early Heart Disease Markers in Blood and Saliva  11 March 2025, Doha, Qatar &#8211; Sidra Medicine, a member of Qatar Foundation, has published a study in Scientific Reports, a journal from Nature Portfolio titled &#8220;Distinctive Blood and Salivary Proteomics Signatures in Qatari Individuals at High Risk for Cardiovascular Disease&#8220;. The study identifies protein markers that can help detect individuals at high risk of cardiovascular disease. These non-invasive methods contribute to advancing personalized healthcare and facilitating early diagnosis. Cardiovascular disease (CVD) is a leading cause of morbidity and mortality globally, accounting for 29 percent1 of all deaths in Qatar, with risk factors like diabetes and hypertension driving the disease burden. In the broader Middle Eastern population, CVD accounts for 34 percent2 of deaths. The Sidra Medicine study offers promising insights into precision medicine, with the potential to transform strategies for managing and preventing CVD. Dr. Souhaila Al Khodor, Director of the Perinatal and Reproductive Health Division and Principal Investigator at the Laboratory of Microbiome and Biomarkers Discovery, said: “Our study is a step forward in advancing precision medicine for cardiovascular disease. We identified eight biomarkers for CVD-risk that appear in both blood and saliva, demonstrating that non-invasive saliva-based testing could serve as an alternative to traditional blood tests. This approach could significantly improve screening efforts, allowing for timely interventions and better management of modifiable risk factors such as diabetes, hypertension, and high cholesterol.” The research, conducted as part of the Microbiome and Biomarkers Discovery lab at Sidra Medicine, was led by Dr. Souhaila Al Khodor and Principal Investigators, Dr. Annalisa Terranegra and Dr. Jean Charles Grivel. The multidisciplinary team also included Dr. Ghada Yousif, Research Specialist and Staff Scientists &#8211; Dr. Selvasankar Murugesan, Dr. Mohamed Nadhir Djekidel and Dr. Giusy Gentilcore. Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine, said: “Qatar has built a world-class ecosystem for precision medicine, integrating genomic research, national biobanking, and targeted healthcare initiatives. With participants recruited through Qatar Biobank and funding from the Qatar National Research Fund, this study demonstrates how we can translate local genetic insights into innovative healthcare solutions that has global implications. By focusing on cardiovascular disease, which has a significant death rate in the region, we are addressing a critical health challenge and working to reduce its impact on the Qatari population.” Sidra Medicine continues to lead in advancing innovative healthcare solutions tailored to the needs of the Qatari population. Through cutting edge research, Qatar is driving breakthroughs in precision medicine, enhancing early diagnosis and risk management for cardiovascular disease. Click here to read the full study, which was awarded via Qatar National Research Fund’s Path to Precision Medicine 2-PPM2 grant under the Qatar Genome Program.</p>
<p>The post <a href="https://businessleadersme.com/sidra-medicine-study-identifies-new-non-invasive-method-for-detecting-heart-disease-risk/">Sidra Medicine Study Identifies New Non-Invasive Method for Detecting Heart Disease Risk</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="2281" class="elementor elementor-2281" data-elementor-post-type="post">
				<div class="elementor-element elementor-element-4699b609 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent" data-id="4699b609" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-130be1e elementor-widget elementor-widget-text-editor" data-id="130be1e" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
									
<p class="wp-block-paragraph"><em>Breakthrough Study Identifies Early Heart Disease Markers in Blood and Saliva</em></p>

<p class="wp-block-paragraph"><strong> 11 March 2025, Doha, Qatar</strong> &#8211; <a href="http://www.sidra.org/">Sidra Medicine</a>, a member of Qatar Foundation, has published a study in <a href="https://www.nature.com/srep/"><em>Scientific Reports</em></a>, a journal from <em>Nature Portfolio</em> titled <em>&#8220;</em><a href="https://www.nature.com/articles/s41598-025-87596-2"><em>Distinctive Blood and Salivary Proteomics Signatures in Qatari Individuals at High Risk for Cardiovascular Disease</em></a><em>&#8220;</em>. The study identifies protein markers that can help detect individuals at high risk of cardiovascular disease. These non-invasive methods contribute to advancing personalized healthcare and facilitating early diagnosis.</p>

<p class="wp-block-paragraph">Cardiovascular disease (CVD) is a leading cause of morbidity and mortality globally, accounting for 29 percent<sup>1</sup> of all deaths in Qatar, with risk factors like diabetes and hypertension driving the disease burden. In the broader Middle Eastern population, CVD accounts for 34 percent<sup>2 </sup>of deaths. The Sidra Medicine study offers promising insights into precision medicine, with the potential to transform strategies for managing and preventing CVD.</p>

<p class="wp-block-paragraph"><a href="https://www.sidra.org/research/our-research/principal-investigators/souhaila-al-khodor-msc-phd">Dr. Souhaila Al Khodor</a>, Director of the Perinatal and Reproductive Health Division and Principal Investigator at the Laboratory of Microbiome and Biomarkers Discovery, said: “Our study is a step forward in advancing precision medicine for cardiovascular disease. We identified eight biomarkers for CVD-risk that appear in both blood and saliva, demonstrating that non-invasive saliva-based testing could serve as an alternative to traditional blood tests. This approach could significantly improve screening efforts, allowing for timely interventions and better management of modifiable risk factors such as diabetes, hypertension, and high cholesterol.”</p>

<p class="wp-block-paragraph">The research, conducted as part of the Microbiome and Biomarkers Discovery lab at Sidra Medicine, was led by Dr. Souhaila Al Khodor and Principal Investigators, Dr. Annalisa Terranegra and Dr. Jean Charles Grivel. The multidisciplinary team also included Dr. Ghada Yousif, Research Specialist and Staff Scientists &#8211; Dr. Selvasankar Murugesan, Dr. Mohamed Nadhir Djekidel and Dr. Giusy Gentilcore.</p>

<p class="wp-block-paragraph"><a href="https://www.sidra.org/research/our-research/principal-investigators/khalid-fakhro-phd">Prof. Khalid Fakhro</a>, Chief Research Officer at Sidra Medicine, said: “Qatar has built a world-class ecosystem for precision medicine, integrating genomic research, national biobanking, and targeted healthcare initiatives. With participants recruited through Qatar Biobank and funding from the Qatar National Research Fund, this study demonstrates how we can translate local genetic insights into innovative healthcare solutions that has global implications. By focusing on cardiovascular disease, which has a significant death rate in the region, we are addressing a critical health challenge and working to reduce its impact on the Qatari population.”</p>

<p class="wp-block-paragraph">Sidra Medicine continues to lead in advancing innovative healthcare solutions tailored to the needs of the Qatari population. Through cutting edge research, Qatar is driving breakthroughs in precision medicine, enhancing early diagnosis and risk management for cardiovascular disease. Click <a href="https://www.nature.com/articles/s41598-025-87596-2">here</a> to read the full study, which was awarded via Qatar National Research Fund’s Path to Precision Medicine 2-PPM2 grant under the Qatar Genome Program.</p>
								</div>
					</div>
				</div>
				</div>
		<p>The post <a href="https://businessleadersme.com/sidra-medicine-study-identifies-new-non-invasive-method-for-detecting-heart-disease-risk/">Sidra Medicine Study Identifies New Non-Invasive Method for Detecting Heart Disease Risk</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Sidra Medicine’s ENT Service Delivers Breakthrough in Airway Surgery</title>
		<link>https://businessleadersme.com/sidra-medicines-ent-service-delivers-breakthrough-in-airway-surgery/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Tue, 04 Mar 2025 19:18:45 +0000</pubDate>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Airway Obstruction]]></category>
		<category><![CDATA[Airway Surgery]]></category>
		<category><![CDATA[Complex Airway Cases]]></category>
		<category><![CDATA[Endoscopic Ear Surgery]]></category>
		<category><![CDATA[ENT Surgery]]></category>
		<category><![CDATA[Epiglottoplasty]]></category>
		<category><![CDATA[International Patients]]></category>
		<category><![CDATA[Medical Innovation]]></category>
		<category><![CDATA[Multidisciplinary Care]]></category>
		<category><![CDATA[Otolaryngology]]></category>
		<category><![CDATA[Pediatric ENT]]></category>
		<category><![CDATA[Pediatric Healthcare]]></category>
		<category><![CDATA[Pediatric Sleep Apnea]]></category>
		<category><![CDATA[Pediatric Surgery]]></category>
		<category><![CDATA[Pediatric Tracheostomy]]></category>
		<category><![CDATA[Qatar]]></category>
		<category><![CDATA[Qatar Foundation]]></category>
		<category><![CDATA[Qatar Healthcare]]></category>
		<category><![CDATA[Sidra Medicine]]></category>
		<category><![CDATA[Sinus Surgery]]></category>
		<category><![CDATA[Skull Base Surgery]]></category>
		<category><![CDATA[Supraglottoplasty]]></category>
		<category><![CDATA[Thyroid Surgery]]></category>
		<category><![CDATA[Tracheostomy Care]]></category>
		<category><![CDATA[Tracheostomy Program]]></category>
		<category><![CDATA[Tracheostomy Removal]]></category>
		<guid isPermaLink="false">https://businessleadersme.com/?p=2192</guid>

					<description><![CDATA[<p>Qatar&#8217;s Only National Pediatric Tracheostomy Program Provides Expert and Innovative Care for Airway Conditions 4 March 2025, Doha, Qatar &#8211; Sidra Medicine, a member of Qatar Foundation, is setting a new benchmark in pediatric healthcare with Qatar’s only national pediatric tracheostomy program. Supporting over 150 patients annually, the program has become a vital resource for families in Qatar, offering cutting-edge care and life-changing outcomes. In a recent success story, the Otolaryngology (ENT) team at Sidra Medicine successfully removed the tracheostomy tube of a 16-year-old patient. The patient experienced airway obstruction just above her vocal cords, which required the placement of a tracheostomy tube below the vocal cords to bypass the obstruction. Living with a breathing tube inserted through her neck was a life-altering condition, significantly limiting her as a high-functioning teenager. Despite undergoing multiple surgeries over the years to address the obstruction, previous attempts to resolve the issue and remove her tracheostomy had been unsuccessful. The team performed a unique combination of an epiglottoplasty and supraglottoplasty tailored specifically to her needs. The individualized approach, a first in Qatar, resolved the obstruction and allowed the patient to breathe normally through her nose for the first time in years. Dr. Taseer Feroze Din, an Attending Pediatric ENT Physician, who led the procedure on the young patient said: “This case highlights the strength of our airway surgical services and innovative approach to complex conditions. Our multidisciplinary team manages multiple new tracheostomies annually, cares for over 50 patients in long-term care, and supports over 100 patients in the community. Our team’s collaborative approach, which is harmonized by our nurse practitioner, Larkin Accinelli, has been pivotal in successes such as this. The aim of our program is to create a system that provides proactive management to prevent complications and optimize safe care for all our tracheostomized patients”. The patient’s mother shared her heartfelt gratitude: “Our daughter was born with a tightening in her throat, unable to breathe normally, and relied on a device to help her for the past 15 years. After five unsuccessful surgeries in the UK, Sidra Medicine here in Qatar, was the only place that could help her. We are deeply grateful to the doctors who provided exceptional care and checked on her tirelessly, even late into the night. It has been a long and painful journey since birth, but now after so many years, she can finally breathe on her own.” Dr. Faisal Abdelkader, Division Chief of Otolaryngology and Audiology at Sidra Medicine said: “Sidra Medicine’s tracheostomy program has doubled the number of successful tracheostomy removals in the past year, enabling children to lead more normal lives. The program has provided comprehensive care to local and international patients, including patients from Kuwait, Jordan, India, and Sri Lanka. We have become a trusted care partner for these families. I am equally proud of our efforts in presenting the development of the national tracheostomy program at international conferences in the USA, UAE and Tanzania, reinforcing our leadership in pediatric airway and tracheostomy care”. In addition to complex airway surgeries, the ENT service at Sidra Medicine provides a wide range of services, including complex sinus surgery, endoscopic ear surgery, pediatric sleep apnea treatment including the latest advances in adenoid and tonsil surgery, anterior skull base leak repair, endoscopic tear duct opening (DCR) and thyroid surgery. Using state-of-the-art equipment and a patient-centered approach, the team ensures exceptional care with optimal outcomes. For international inquiries about Sidra Medicine’s ENT services, please contact International.services@sidra.org. If you are based in Qatar, please call 40033333 for more information.</p>
<p>The post <a href="https://businessleadersme.com/sidra-medicines-ent-service-delivers-breakthrough-in-airway-surgery/">Sidra Medicine’s ENT Service Delivers Breakthrough in Airway Surgery</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="2192" class="elementor elementor-2192" data-elementor-post-type="post">
				<div class="elementor-element elementor-element-54e3e2dd e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent" data-id="54e3e2dd" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-7d94be65 elementor-widget elementor-widget-text-editor" data-id="7d94be65" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
									
<p class="wp-block-paragraph"><strong><em>Qatar&#8217;s Only National Pediatric Tracheostomy Program Provides Expert and Innovative Care for Airway Conditions</em></strong></p>

<p class="wp-block-paragraph"><strong>4 March 2025, Doha, Qatar</strong> &#8211; <a href="http://www.sidra.org/">Sidra Medicine</a>, a member of Qatar Foundation, is setting a new benchmark in pediatric healthcare with Qatar’s only national pediatric tracheostomy program. Supporting over 150 patients annually, the program has become a vital resource for families in Qatar, offering cutting-edge care and life-changing outcomes.</p>

<p class="wp-block-paragraph">In a recent success story, the <a href="https://www.sidra.org/clinics-services/childrens-and-young-people/ear-nose-and-throat">Otolaryngology (ENT)</a> team at Sidra Medicine successfully removed the tracheostomy tube of a 16-year-old patient. The patient experienced airway obstruction just above her vocal cords, which required the placement of a tracheostomy tube below the vocal cords to bypass the obstruction. Living with a breathing tube inserted through her neck was a life-altering condition, significantly limiting her as a high-functioning teenager. Despite undergoing multiple surgeries over the years to address the obstruction, previous attempts to resolve the issue and remove her tracheostomy had been unsuccessful.</p>

<p class="wp-block-paragraph">The team performed a unique combination of an epiglottoplasty and supraglottoplasty tailored specifically to her needs. The individualized approach, a first in Qatar, resolved the obstruction and allowed the patient to breathe normally through her nose for the first time in years.</p>

<div class="wp-block-media-text has-media-on-the-right is-stacked-on-mobile" style="grid-template-columns: auto 30%;">
<div class="wp-block-media-text__content">
<p class="wp-block-paragraph"><a href="https://www.sidra.org/doctors-and-nurse-practitioners/taseer-feroze-din">Dr. Taseer Feroze Din</a>, an Attending Pediatric ENT Physician, who led the procedure on the young patient said: “This case highlights the strength of our airway surgical services and innovative approach to complex conditions. Our multidisciplinary team manages multiple new tracheostomies annually, cares for over 50 patients in long-term care, and supports over 100 patients in the community. Our team’s collaborative approach, which is harmonized by our nurse practitioner, Larkin Accinelli, has been pivotal in successes such as this. The aim of our program is to create a system that provides proactive management to prevent complications and optimize safe care for all our tracheostomized patients”.</p>
</div>
<figure class="wp-block-media-text__media"><img decoding="async" src="https://businessleadersme.com/wp-content/uploads/2025/03/Sidra-Medicine1.jpg" alt="Sidra Medicine" /></figure>
</div>

<p class="wp-block-paragraph">The patient’s mother shared her heartfelt gratitude: “Our daughter was born with a tightening in her throat, unable to breathe normally, and relied on a device to help her for the past 15 years. After five unsuccessful surgeries in the UK, Sidra Medicine here in Qatar, was the only place that could help her. We are deeply grateful to the doctors who provided exceptional care and checked on her tirelessly, even late into the night. It has been a long and painful journey since birth, but now after so many years, she can finally breathe on her own.”</p>

<div class="wp-block-media-text is-stacked-on-mobile" style="grid-template-columns: 30% auto;">
<figure class="wp-block-media-text__media"><img decoding="async" src="https://businessleadersme.com/wp-content/uploads/2025/03/Sidra-Medicine2.jpg" alt="Sidra Medicine" /></figure>
<div class="wp-block-media-text__content">
<p class="wp-block-paragraph"><a href="https://www.sidra.org/doctors/faisal-abdulkader/">Dr. Faisal Abdelkader</a>, Division Chief of Otolaryngology and Audiology at Sidra Medicine said: “Sidra Medicine’s tracheostomy program has doubled the number of successful tracheostomy removals in the past year, enabling children to lead more normal lives. The program has provided comprehensive care to local and international patients, including patients from Kuwait, Jordan, India, and Sri Lanka. We have become a trusted care partner for these families. I am equally proud of our efforts in presenting the development of the national tracheostomy program at international conferences in the USA, UAE and Tanzania, reinforcing our leadership in pediatric airway and tracheostomy care”.</p>
</div>
</div>

<p class="wp-block-paragraph">In addition to complex airway surgeries, the ENT service at Sidra Medicine provides a wide range of services, including complex sinus surgery, endoscopic ear surgery, pediatric sleep apnea treatment including the latest advances in adenoid and tonsil surgery, anterior skull base leak repair, endoscopic tear duct opening (DCR) and thyroid surgery. Using state-of-the-art equipment and a patient-centered approach, the team ensures exceptional care with optimal outcomes. For international inquiries about Sidra Medicine’s ENT services, please contact <a href="mailto:International.services@sidra.org">International.services@sidra.org</a>. If you are based in Qatar, please call 40033333 for more information.</p>
								</div>
					</div>
				</div>
				</div>
		<p>The post <a href="https://businessleadersme.com/sidra-medicines-ent-service-delivers-breakthrough-in-airway-surgery/">Sidra Medicine’s ENT Service Delivers Breakthrough in Airway Surgery</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Minister of Public Health Launches “Sehatuha” Campaign Led by Weill Cornell Medicine-Qatar</title>
		<link>https://businessleadersme.com/minister-of-public-health-launches-sehatuha-campaign-led-by-weill-cornell-medicine-qatar/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Thu, 27 Feb 2025 09:13:02 +0000</pubDate>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Alumni Network]]></category>
		<category><![CDATA[Community Health]]></category>
		<category><![CDATA[digital health]]></category>
		<category><![CDATA[Hamad Medical Corporation]]></category>
		<category><![CDATA[Health Education]]></category>
		<category><![CDATA[Health Empowerment]]></category>
		<category><![CDATA[Health Lectures]]></category>
		<category><![CDATA[Health Workshops]]></category>
		<category><![CDATA[Healthcare Awareness]]></category>
		<category><![CDATA[healthcare innovation]]></category>
		<category><![CDATA[Healthcare Leaders]]></category>
		<category><![CDATA[Healthy Lifestyle]]></category>
		<category><![CDATA[HMC]]></category>
		<category><![CDATA[Medical Awareness]]></category>
		<category><![CDATA[Medical Campaign]]></category>
		<category><![CDATA[Mental Well-being]]></category>
		<category><![CDATA[National Health Strategy]]></category>
		<category><![CDATA[Physical Health]]></category>
		<category><![CDATA[Preventive Healthcare]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Qatar Foundation]]></category>
		<category><![CDATA[Qatar Health]]></category>
		<category><![CDATA[QF]]></category>
		<category><![CDATA[Sehatuha]]></category>
		<category><![CDATA[Self-care]]></category>
		<category><![CDATA[Sheikha Hind bint Hamad Al Thani]]></category>
		<category><![CDATA[Sheikha Moza bint Nasser]]></category>
		<category><![CDATA[WCM-Q]]></category>
		<category><![CDATA[Weill Cornell Medicine-Qatar]]></category>
		<category><![CDATA[Women's Health]]></category>
		<category><![CDATA[Women's Healthcare]]></category>
		<category><![CDATA[Women's Well-being]]></category>
		<guid isPermaLink="false">https://businessleadersme.com/?p=2082</guid>

					<description><![CDATA[<p>Doha – February 26, 2025: His Excellency Mr Mansoor Bin Ebrahim Al Mahmoud, Minister of Public Health, inaugurated today the “Sehatuha” campaign, launched by Weill Cornell Medicine-Qatar (WCM-Q). This initiative marks a significant milestone in efforts to enhance women&#8217;s health, emphasizing the crucial role women play in society and the urgent need to prioritize their well-being. Dr Javaid Sheikh, Dean of WCM-Q, attended the launch ceremony alongside over 70 of the college&#8217;s alumni. The event featured the unveiling of the campaign&#8217;s visual identity, a film narrating the initiative&#8217;s journey and intended impact, as well as excerpts from web and podcast episodes presented by alumni. Additionally, Dr Bothina Al-Mulla and Dr Sulaiman Alshakhs, both graduates of WCM-Q and currently Practicing at Hamad Medical Corporation (HMC), shared their involvement in the campaign and underscored the importance of such initiatives. The Sehatuha campaign represents a dedicated effort to drive tangible change in line with WCM-Q’s mission to provide comprehensive healthcare solutions and foster community well-being. Inspired by the principle that “prevention is better than cure,” the campaign aims to raise awareness about health issues and preventive measures. Commenting on the initiative, His Excellency Mr Mansoor Bin Ebrahim Al Mahmoud highlighted the importance of Sehatuha in promoting women&#8217;s well-being. He stated, “This campaign supports our collective efforts under the National Health Strategy 2024-2030 to improve the health and well-being of the population, encouraging behavioral shifts towards greater health awareness and empowering individuals to take a proactive role in managing their health.” His Excellency further explained that women&#8217;s health had been a priority within the Second National Health Strategy, with intensified efforts to empower women and provide them with the necessary knowledge to lead healthier lives. His Excellency added, “Building on the significant achievements made, our new strategy continues to focus on improving health outcomes, with reproductive health as one of its key initiatives.” The Minister of Public Health also reaffirmed the Ministry’s commitment to supporting innovative health initiatives aimed at enhancing public health, commending the vital role played by WCM-Q in this domain. Additionally, His Excellency praised the support of Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development (QF), for the healthcare sector, as well as QF’s remarkable contributions to the advancement of Qatar’s healthcare system and the creation of a healthier society. In his welcome speech, Dr Javaid Sheikh praised Qatar’s visionary leadership and the inspiring contributions of female role models. He said, “Inspired by Her Highness Sheikha Moza bint Nasser, Sehatuha is more than just a health campaign—it’s a transformative movement that redefines healthcare and paves the way for a healthier, more empowered future for women. Through Sehatuha, we are creating a lifelong platform for women to learn, connect, and grow in their health journey, fostering a culture of self-care, community engagement, and a legacy that will positively impact future generations.” Dr Sheikh concluded by expressing his gratitude to Her Excellency Sheikha Hind bint Hamad Al Thani, Vice Chairperson and CEO of Qatar Foundation (QF), for her continued support of WCM-Q alumni and for empowering future generations of healthcare leaders. Sehatuha draws strength from its profound connection to the community, bridging gaps through WCM-Q’s alumni network. These healthcare leaders, who are rooted in the community and equipped with firsthand knowledge of its challenges, serve as key catalysts for change. The initiative was developed to support and raise awareness of women’s health issues, drawing on the experiences of alumni working across diverse specialties and healthcare institutions. Many WCM-Q alumni, with their deep roots in Qatar, either as nationals or long-term residents, are exceptionally positioned to champion and advance women’s healthcare education. Sehatuha addresses a woman’s entire lifecycle, from childhood and adolescence to motherhood and her golden years, highlighting health concerns specific to each stage. Utilizing state-of-the-art technology and digital platforms, it promotes physical health, mental and emotional well-being, healthy lifestyle habits, and self-care. Additionally, community engagement activities will be centered on these key themes. Beyond web and podcast episodes featuring WCM-Q alumni and experts, the Sehatuha campaign will host a series of workshops and lectures throughout the year. This dedicated approach provides practical knowledge and shared experiences to inspire and empower women in making informed choices about their health and well-being. By fostering a holistic and integrated health culture, Sehatuha aims to enhance women&#8217;s well-being, support a healthier society, and promote both physical and emotional health in Qatar and beyond.</p>
<p>The post <a href="https://businessleadersme.com/minister-of-public-health-launches-sehatuha-campaign-led-by-weill-cornell-medicine-qatar/">Minister of Public Health Launches “Sehatuha” Campaign Led by Weill Cornell Medicine-Qatar</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="2082" class="elementor elementor-2082" data-elementor-post-type="post">
				<div class="elementor-element elementor-element-38cf44f e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent" data-id="38cf44f" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-1f25bc88 elementor-widget elementor-widget-text-editor" data-id="1f25bc88" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
									
<p class="wp-block-paragraph"><strong>Doha – February 26, 2025:</strong> His Excellency Mr Mansoor Bin Ebrahim Al Mahmoud, Minister of Public Health, inaugurated today the “Sehatuha” campaign, launched by Weill Cornell Medicine-Qatar (WCM-Q). This initiative marks a significant milestone in efforts to enhance women&#8217;s health, emphasizing the crucial role women play in society and the urgent need to prioritize their well-being.</p>

<p class="wp-block-paragraph">Dr Javaid Sheikh, Dean of WCM-Q, attended the launch ceremony alongside over 70 of the college&#8217;s alumni. The event featured the unveiling of the campaign&#8217;s visual identity, a film narrating the initiative&#8217;s journey and intended impact, as well as excerpts from web and podcast episodes presented by alumni. Additionally, Dr Bothina Al-Mulla and Dr Sulaiman Alshakhs, both graduates of WCM-Q and currently Practicing at Hamad Medical Corporation (HMC), shared their involvement in the campaign and underscored the importance of such initiatives.</p>

<div>
<figure class="wp-block-image size-large"><img decoding="async" src="https://res.cloudinary.com/dtz0urit6/image/upload/f_webp,q_auto/cloudinary-tools-uploads/d4gwvpe3zpp4d1ik8qfc.webp" alt="cloudinary-tools-uploads/d4gwvpe3zpp4d1ik8qfc" /></figure>
</div>

<p class="wp-block-paragraph">The Sehatuha campaign represents a dedicated effort to drive tangible change in line with WCM-Q’s mission to provide comprehensive healthcare solutions and foster community well-being. Inspired by the principle that “prevention is better than cure,” the campaign aims to raise awareness about health issues and preventive measures.</p>

<p class="wp-block-paragraph">Commenting on the initiative, His Excellency Mr Mansoor Bin Ebrahim Al Mahmoud highlighted the importance of Sehatuha in promoting women&#8217;s well-being. He stated, “This campaign supports our collective efforts under the National Health Strategy 2024-2030 to improve the health and well-being of the population, encouraging behavioral shifts towards greater health awareness and empowering individuals to take a proactive role in managing their health.”</p>

<div>
<figure class="wp-block-image size-large"><img decoding="async" src="https://res.cloudinary.com/dtz0urit6/image/upload/f_webp,q_auto/cloudinary-tools-uploads/s5zqniteawcslnaicjhf.webp" alt="cloudinary-tools-uploads/s5zqniteawcslnaicjhf" /></figure>
</div>

<p class="wp-block-paragraph">His Excellency further explained that women&#8217;s health had been a priority within the Second National Health Strategy, with intensified efforts to empower women and provide them with the necessary knowledge to lead healthier lives. His Excellency added, “Building on the significant achievements made, our new strategy continues to focus on improving health outcomes, with reproductive health as one of its key initiatives.”</p>

<p class="wp-block-paragraph">The Minister of Public Health also reaffirmed the Ministry’s commitment to supporting innovative health initiatives aimed at enhancing public health, commending the vital role played by WCM-Q in this domain.</p>

<p class="wp-block-paragraph">Additionally, His Excellency praised the support of Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation for Education, Science and Community Development (QF), for the healthcare sector, as well as QF’s remarkable contributions to the advancement of Qatar’s healthcare system and the creation of a healthier society.</p>

<div>
<figure class="wp-block-image size-large"><img decoding="async" src="https://res.cloudinary.com/dtz0urit6/image/upload/f_webp,q_auto/cloudinary-tools-uploads/bebd20ikkxwccswbphl0.webp" alt="cloudinary-tools-uploads/bebd20ikkxwccswbphl0" /></figure>
</div>

<p class="wp-block-paragraph">In his welcome speech, Dr Javaid Sheikh praised Qatar’s visionary leadership and the inspiring contributions of female role models. He said, “Inspired by Her Highness Sheikha Moza bint Nasser, Sehatuha is more than just a health campaign—it’s a transformative movement that redefines healthcare and paves the way for a healthier, more empowered future for women. Through Sehatuha, we are creating a lifelong platform for women to learn, connect, and grow in their health journey, fostering a culture of self-care, community engagement, and a legacy that will positively impact future generations.” Dr Sheikh concluded by expressing his gratitude to Her Excellency Sheikha Hind bint Hamad Al Thani, Vice Chairperson and CEO of Qatar Foundation (QF), for her continued support of WCM-Q alumni and for empowering future generations of healthcare leaders.</p>

<p class="wp-block-paragraph">Sehatuha draws strength from its profound connection to the community, bridging gaps through WCM-Q’s alumni network. These healthcare leaders, who are rooted in the community and equipped with firsthand knowledge of its challenges, serve as key catalysts for change. The initiative was developed to support and raise awareness of women’s health issues, drawing on the experiences of alumni working across diverse specialties and healthcare institutions. Many WCM-Q alumni, with their deep roots in Qatar, either as nationals or long-term residents, are exceptionally positioned to champion and advance women’s healthcare education.</p>

<div>
<figure class="wp-block-image size-large"><img decoding="async" class="wp-image-2083" src="https://businessleadersme.com/wp-content/uploads/2025/02/Sehatuha2-1024x576.jpg" alt="Minister of Public Health Launches “Sehatuha” Campaign Led by Weill Cornell Medicine-Qatar" /></figure>
</div>

<p class="wp-block-paragraph">Sehatuha addresses a woman’s entire lifecycle, from childhood and adolescence to motherhood and her golden years, highlighting health concerns specific to each stage. Utilizing state-of-the-art technology and digital platforms, it promotes physical health, mental and emotional well-being, healthy lifestyle habits, and self-care. Additionally, community engagement activities will be centered on these key themes. Beyond web and podcast episodes featuring WCM-Q alumni and experts, the Sehatuha campaign will host a series of workshops and lectures throughout the year. This dedicated approach provides practical knowledge and shared experiences to inspire and empower women in making informed choices about their health and well-being. By fostering a holistic and integrated health culture, Sehatuha aims to enhance women&#8217;s well-being, support a healthier society, and promote both physical and emotional health in Qatar and beyond.</p>
								</div>
					</div>
				</div>
				</div>
		<p>The post <a href="https://businessleadersme.com/minister-of-public-health-launches-sehatuha-campaign-led-by-weill-cornell-medicine-qatar/">Minister of Public Health Launches “Sehatuha” Campaign Led by Weill Cornell Medicine-Qatar</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Sidra Medicine and Rasmal Ventures Partner to Drive Digital Health Innovation in Qatar</title>
		<link>https://businessleadersme.com/sidra-medicine-and-rasmal-ventures-partner-to-drive-digital-health-innovation-in-qatar/</link>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Wed, 26 Feb 2025 09:39:12 +0000</pubDate>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AI in healthcare]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[cell therapy]]></category>
		<category><![CDATA[clinical research]]></category>
		<category><![CDATA[digital health]]></category>
		<category><![CDATA[digital healthcare solutions]]></category>
		<category><![CDATA[Doha]]></category>
		<category><![CDATA[e-health]]></category>
		<category><![CDATA[entrepreneurship]]></category>
		<category><![CDATA[gene therapy]]></category>
		<category><![CDATA[genomics]]></category>
		<category><![CDATA[health-tech]]></category>
		<category><![CDATA[healthcare innovation]]></category>
		<category><![CDATA[healthcare startups]]></category>
		<category><![CDATA[healthcare transformation]]></category>
		<category><![CDATA[medical education]]></category>
		<category><![CDATA[medical research]]></category>
		<category><![CDATA[patient-centric care]]></category>
		<category><![CDATA[Qatar]]></category>
		<category><![CDATA[Qatar Foundation]]></category>
		<category><![CDATA[Qatar National Vision 2030]]></category>
		<category><![CDATA[Rasmal Ventures]]></category>
		<category><![CDATA[Sidra Medicine]]></category>
		<category><![CDATA[Startup Ecosystem]]></category>
		<category><![CDATA[telemedicine]]></category>
		<category><![CDATA[venture capital]]></category>
		<category><![CDATA[Wearable Technology]]></category>
		<category><![CDATA[Web Summit Qatar]]></category>
		<guid isPermaLink="false">https://businessleadersme.com/?p=2066</guid>

					<description><![CDATA[<p>Advancing Healthcare Through E-health Innovation and Startup Integration 25 February 2025, Doha, Qatar &#8211; Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with Rasmal Ventures, Qatar’s first venture capital firm. The strategic partnership, announced at the Web Summit Qatar 2025, marks a significant step in the hospital’s role in supporting and advancing digital health innovation in Qatar and beyond. Rasmal Ventures, with its extensive portfolio of global technology companies, will introduce Sidra Medicine to high-potential e-health startups and provide strategic support to incorporate innovative solutions into Sidra Medicine’s operations. In return, Sidra Medicine will contribute its clinical and research expertise to evaluate and refine the startups’ healthcare technologies, ensuring they are effective, scalable, and patient-focused. Moreover, the two organizations will develop entrepreneurship programs that encourage the development and growth of a Health-Tech sector for Qatar. Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine said: “This partnership highlights our commitment to establishing Sidra Medicine as a leading healthcare innovation hub in Qatar, in alignment with the Qatar National Vision 2030. By collaborating with Rasmal Ventures, we are building upon our current strengths in clinical care, genomics and cell and gene therapy, and taking a proactive approach to adopting innovative technologies and transforming Sidra Medicine into a living lab for entrepreneurial ventures from across Qatar and the world.” The MOU establishes a collaborative framework between the two entities to facilitate the exchange of expertise and best practices in e-health innovations. Through this partnership, Sidra Medicine and Rasmal Ventures aim to drive advancements in innovation, focusing on digital healthcare solutions such as patient-centric artificial intelligence (AI) technologies, telemedicine platforms, and wearable devices. Alexander Wiedmer, Co-Managing Partner at Rasmal Ventures said: “At Rasmal Ventures, we believe that innovation is key to transforming healthcare. Our partnership with Sidra Medicine represents a unique opportunity to bring the latest digital health technologies to the forefront, empowering Qatar’s healthcare system to deliver smarter, more efficient, and patient-centered care.” As part of the agreement, the two entities will host joint workshops, pilot studies, and discussions to validate the efficacy of emerging technologies and foster an open environment for innovation. This partnership positions Sidra Medicine as a driving force in healthcare innovation, creating valuable opportunities for biotech and healthtech leaders. It also underscores Sidra Medicine’s role as a premier destination for medical education and research, attracting innovators and nurturing the development of next-generation healthcare solutions.</p>
<p>The post <a href="https://businessleadersme.com/sidra-medicine-and-rasmal-ventures-partner-to-drive-digital-health-innovation-in-qatar/">Sidra Medicine and Rasmal Ventures Partner to Drive Digital Health Innovation in Qatar</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></description>
										<content:encoded><![CDATA[		<div data-elementor-type="wp-post" data-elementor-id="2066" class="elementor elementor-2066" data-elementor-post-type="post">
				<div class="elementor-element elementor-element-7a8ce7a6 e-flex e-con-boxed wpr-particle-no wpr-jarallax-no wpr-parallax-no wpr-sticky-section-no wpr-column-slider-no wpr-equal-height-no e-con e-parent" data-id="7a8ce7a6" data-element_type="container" data-e-type="container">
					<div class="e-con-inner">
				<div class="elementor-element elementor-element-2306c24d elementor-widget elementor-widget-text-editor" data-id="2306c24d" data-element_type="widget" data-e-type="widget" data-widget_type="text-editor.default">
									
<p class="wp-block-paragraph"><em>Advancing Healthcare Through E-health Innovation and Startup Integration</em></p>



<p class="wp-block-paragraph"><strong>25 February 2025, Doha, Qatar</strong> &#8211; <a href="http://www.sidra.org/">Sidra Medicine</a>, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with <a href="https://www.rasmalventures.com/en">Rasmal Ventures</a>, Qatar’s first venture capital firm. The strategic partnership, announced at the Web Summit Qatar 2025, marks a significant step in the hospital’s role in supporting and advancing digital health innovation in Qatar and beyond.</p>



<p class="wp-block-paragraph">Rasmal Ventures, with its extensive portfolio of global technology companies, will introduce Sidra Medicine to high-potential e-health startups and provide strategic support to incorporate innovative solutions into Sidra Medicine’s operations. In return, Sidra Medicine will contribute its clinical and research expertise to evaluate and refine the startups’ healthcare technologies, ensuring they are effective, scalable, and patient-focused. Moreover, the two organizations will develop entrepreneurship programs that encourage the development and growth of a Health-Tech sector for Qatar.</p>



<p class="wp-block-paragraph"><a></a><a href="https://www.sidra.org/doctors/khalid-fakhro/">Prof. Khalid Fakhro</a>, Chief Research Officer at Sidra Medicine said: “This partnership highlights our commitment to establishing Sidra Medicine as a leading healthcare innovation hub in Qatar, in alignment with the Qatar National Vision 2030. By collaborating with Rasmal Ventures, we are building upon our current strengths in clinical care, genomics and cell and gene therapy, and taking a proactive approach to adopting innovative technologies and transforming Sidra Medicine into a living lab for entrepreneurial ventures from across Qatar and the world.”</p>



<p class="wp-block-paragraph">The MOU establishes a collaborative framework between the two entities to facilitate the exchange of expertise and best practices in e-health innovations. Through this partnership, Sidra Medicine and Rasmal Ventures aim to drive advancements in innovation, focusing on digital healthcare solutions such as patient-centric artificial intelligence (AI) technologies, telemedicine platforms, and wearable devices.</p>



<p class="wp-block-paragraph"><a href="https://www.linkedin.com/in/alexwiedmer13061968/">Alexander Wiedmer</a>, Co-Managing Partner at Rasmal Ventures said: “At Rasmal Ventures, we believe that innovation is key to transforming healthcare. Our partnership with Sidra Medicine represents a unique opportunity to bring the latest digital health technologies to the forefront, empowering Qatar’s healthcare system to deliver smarter, more efficient, and patient-centered care.”</p>



<p class="wp-block-paragraph">As part of the agreement, the two entities will host joint workshops, pilot studies, and discussions to validate the efficacy of emerging technologies and foster an open environment for innovation. This partnership positions Sidra Medicine as a driving force in healthcare innovation, creating valuable opportunities for biotech and healthtech leaders. It also underscores Sidra Medicine’s role as a premier destination for medical education and research, attracting innovators and nurturing the development of next-generation healthcare solutions.</p>
								</div>
					</div>
				</div>
				</div>
		<p>The post <a href="https://businessleadersme.com/sidra-medicine-and-rasmal-ventures-partner-to-drive-digital-health-innovation-in-qatar/">Sidra Medicine and Rasmal Ventures Partner to Drive Digital Health Innovation in Qatar</a> appeared first on <a href="https://businessleadersme.com">Business Leaders ME | Qatar &amp; Middle East Business News Magazine</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
